Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28315654 | 1.00 | CES2 (0.48) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL18614056 | 1.00 | CES2 (0.48) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL18613979 | 0.97 | CES2 (0.46) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL743494 | 0.88 | — | — | |
| SCHEMBL7167550 | 0.81 | CES2 (0.46) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL7169801 | 0.81 | CES2 (0.46) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL7168781 | 0.81 | CES2 (0.46) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL198724 | 0.79 | — | — | |
| SCHEMBL20500817 | 0.79 | CES2 (0.44) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL11106193 | 0.79 | TSHR (0.43) | LMNAMEN1KMT2AFAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11253111-B2 | Skin care product dispensers and associated self-foaming compositions | GPCP IP HOLDINGS LLC (US) | 2022-02-22 | — | — | US | disclosed |
| US-20210052115-A1 | SKIN CARE PRODUCT DISPENSERS AND ASSOCIATED SELF-FOAMING COMPOSITIONS | GPCP IP HOLDINGS LLC | 2021-02-25 | — | — | US | disclosed |
| US-9757701-B2 | Method for producing oil-in-water emulsions from self-emulsifying gel concentrates | SASOL GERMANY GMBH (DE) | 2017-09-12 | — | — | US | disclosed |
| US-20110033413-A1 | METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | KWETKAT KLAUS | 2011-02-10 | — | — | US | disclosed |
| US-20110033555-A1 | METHOD FOR PRODUCING WAX IN WATER DISPERSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | KWETKAT KLAUS | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033555-A1 | METHOD FOR PRODUCING WAX IN WATER DISPERSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | LSS, LIPA, ERG28 | CES2 2094/4885CES1 1021/4885LMNA 2390/4885 |
| US-20110033413-A1 | METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | LIPA, CCNO, CEL | CES2 3882/4885CES1 2431/4885LMNA 2566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.